Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Thierry Poynard(Pitié-Salpêtrière Hospital), Patrick Marcellin(Hôpital Beaujon), Samuel S. Lee(University of Calgary), Christian Niederau(Heinrich Heine University Düsseldorf), Gerald Minuk(University of Manitoba), G. Idéo(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Vincent G. Bain(University of Alberta), Jenny Heathcote(Toronto General Hospital), Stefan Zeuzem(Goethe University Frankfurt), C. Trépo(Hôtel-Dieu de Lyon), Janice K. Albrecht
Cited by 2,332
Abstract
Related Papers
No related papers found
Powered by citation graph analysis